View Clinical Trial (Medical Research Study)
Metastatic Colorectal Cancer - PEAK Study - Franklin IN (Clinical Trial 6505)
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.
|
 |
 |
| City: |
|
Franklin |
| State: |
|
IN |
| Zip Code: |
|
46131 |
| Study summary: |
|
Individuals with colorectal cancer that has metastasized (spread) are invited to inquire about participation in a clinical research study. This study will evaluate an investigational fully human monoclonal antibody combined with chemotherapy to see if it will extend survival for a longer period of time, compared to the best available standard of care regimen. Monoclonal antibodies are substances produced in a laboratory that can locate and bind to cancer cells by recognizing specific substances on cancer cells. These antibodies are used to find and attack tumors.
|
| Qualified participants must: |
|
• Have unresectable (inoperable) colorectal cancer that has metastasized (spread)
•
Be at least 18 years of age
•
Not have received a prior treatment regimen for their advanced-stage colorectal cancer
•
Meet other enrollment criteria |
| Participants will receive: |
|
Study-related medication and study-related procedures at no cost |
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or effectiveness of new drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at and participating in a study at About Clinical Trials or take the Participation Quiz to find out if you are a good candidate for clinical trial participation.